Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 1
1989 1
1992 1
1996 1
1997 1
1998 3
1999 4
2000 2
2001 2
2002 7
2003 4
2004 8
2005 8
2006 5
2007 2
2008 5
2009 4
2010 6
2011 8
2012 7
2013 11
2014 12
2015 6
2016 6
2017 12
2018 11
2019 14
2020 7
2021 14
2022 10
2023 12
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Oligoarticular Still Disease"
Page 1
Juvenile Idiopathic Arthritis.
Barut K, Adrovic A, Şahin S, Kasapçopur Ö. Barut K, et al. Balkan Med J. 2017 Apr 5;34(2):90-101. doi: 10.4274/balkanmedj.2017.0111. Balkan Med J. 2017. PMID: 28418334 Free PMC article.
Juvenile idiopathic arthritis is the most common chronic rheumatic disease of unknown aetiology in childhood and predominantly presents with peripheral arthritis. ...Systemic juvenile idiopathic arthritis, which is one of the most frequen …
Juvenile idiopathic arthritis is the most common chronic rheumatic disease of unknown aetiology in childhood and predom …
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial.
Ramanan AV, Quartier P, Okamoto N, Foeldvari I, Spindler A, Fingerhutová Š, Antón J, Wang Z, Meszaros G, Araújo J, Liao R, Keller S, Brunner HI, Ruperto N; JUVE-BASIS investigators; Paediatric Rheumatology International Trials Organisation. Ramanan AV, et al. Lancet. 2023 Aug 12;402(10401):555-570. doi: 10.1016/S0140-6736(23)00921-2. Epub 2023 Jul 6. Lancet. 2023. PMID: 37423231 Clinical Trial.
We enrolled patients (aged 2 to <18 years) with polyarticular juvenile idiopathic arthritis (positive or negative for rheumatoid factor), extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or juveni …
We enrolled patients (aged 2 to <18 years) with polyarticular juvenile idiopathic arthritis (positive or negative for rheum …
Juvenile idiopathic arthritis and its associated uveitis.
Maleki A, Patel PD, Foster CS. Maleki A, et al. Expert Rev Clin Immunol. 2023 Jul-Dec;19(9):1157-1169. doi: 10.1080/1744666X.2023.2231154. Epub 2023 Jul 4. Expert Rev Clin Immunol. 2023. PMID: 37401872 Review.
INTRODUCTION: Juvenile idiopathic arthritis is the most common chronic rheumatologic disease in children. ...AREAS COVERED: In this review article, we discussed epidemiology, risk factors, clinical presentation, supportive laboratory tests, treatment o …
INTRODUCTION: Juvenile idiopathic arthritis is the most common chronic rheumatologic disease in children. ...AREAS COVE …
Juvenile rheumatoid arthritis.
Naz S, Mushtaq A, Rehman S, Bari A, Maqsud A, Khan MZ, Ahmad TM. Naz S, et al. J Coll Physicians Surg Pak. 2013 Jun;23(6):409-12. J Coll Physicians Surg Pak. 2013. PMID: 23763801
OBJECTIVE: To determine the spectrum of clinical presentation, laboratory parameters and drug therapy in patients with Juvenile Rheumatoid Arthritis (JRA). ...Polyarthritis was found in 71.9% (n = 133) followed by oligoarthritis (22.7%, n = 42) and systemic o …
OBJECTIVE: To determine the spectrum of clinical presentation, laboratory parameters and drug therapy in patients with Juvenile …
Prediction of inactive disease and relapse in oligoarticular juvenile idiopathic arthritis.
Sezer M, Aydın F, Kurt T, Tekgöz N, Tekin ZE, Karagöl C, Çakar N, Acar B. Sezer M, et al. Mod Rheumatol. 2021 Sep;31(5):1025-1030. doi: 10.1080/14397595.2020.1836788. Epub 2020 Oct 27. Mod Rheumatol. 2021. PMID: 33050742
OBJECTIVE: The aim of this study is to describe clinical features of patients with oligoarticular juvenile idiopathic arthritis (JIA) who achieved inactive disease at 3rd month and also to determine the predictors of relapse and extended course. …
OBJECTIVE: The aim of this study is to describe clinical features of patients with oligoarticular juvenile idiopathic …
Glucocorticoid treatment in juvenile idiopathic arthritis.
Batu ED. Batu ED. Rheumatol Int. 2019 Jan;39(1):13-27. doi: 10.1007/s00296-018-4168-0. Epub 2018 Oct 1. Rheumatol Int. 2019. PMID: 30276425 Review.
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease of joints in childhood. ...Although systemic glucocorticoid use decreased with the introduction of biologic drugs, intraarticular glucocorticoid injections (IAGI) with nonsteroid …
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease of joints in childhood. ...Although sy …
Juvenile arthritis with oligoarticular onset.
Pelkonen PM. Pelkonen PM. Baillieres Clin Rheumatol. 1998 May;12(2):273-86. doi: 10.1016/s0950-3579(98)80019-8. Baillieres Clin Rheumatol. 1998. PMID: 9890098 Review.
Patients with oligoarticular onset of juvenile arthritis form a large group that is heterogeneous with regard to clinical presentation, further evolution and outcome. The three established subgroups do not cover the whole patient population and are not …
Patients with oligoarticular onset of juvenile arthritis form a large group that is heterogeneous with regard to cli …
Intra-articular injections of biological disease-modifying anti-rheumatic drugs in inflammatory arthropathies: An up-to-date narrative review.
Al Khayyat SG, Conticini E, Falsetti P, Fogliame G, Gentileschi S, Baldi C, Bardelli M, Migliore A, Cantarini L, Frediani B. Al Khayyat SG, et al. Joint Bone Spine. 2023 Dec;90(6):105598. doi: 10.1016/j.jbspin.2023.105598. Epub 2023 Jun 2. Joint Bone Spine. 2023. PMID: 37271277 Review.
INTRODUCTION: Since the 1990s thebiological disease-modifying anti-rheumatic drugs (bDMARDs) have revolutionized the treatment of chronic dysimmune inflammatory arthropathies such as Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondylarthritis. ...Thr …
INTRODUCTION: Since the 1990s thebiological disease-modifying anti-rheumatic drugs (bDMARDs) have revolutionized the treatment of chr …
Methotrexate for juvenile idiopathic arthritis.
Tan J, Renton WD, Whittle SL, Takken T, Johnston RV, Tiller G, Munro J, Buchbinder R. Tan J, et al. Cochrane Database Syst Rev. 2024 Feb 9;2(2):CD003129. doi: 10.1002/14651858.CD003129.pub2. Cochrane Database Syst Rev. 2024. PMID: 38334147 Review.
BACKGROUND: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in childhood. ...The study that evaluated methotrexate plus IAGC therapy versus IAGC therapy alone recruited children and young people with the oligoarticular disea …
BACKGROUND: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in childhood. ...The study that ev …
Th17 and Th1 Lymphocytes in Oligoarticular Juvenile Idiopathic Arthritis.
Maggi L, Mazzoni A, Cimaz R, Liotta F, Annunziato F, Cosmi L. Maggi L, et al. Front Immunol. 2019 Mar 14;10:450. doi: 10.3389/fimmu.2019.00450. eCollection 2019. Front Immunol. 2019. PMID: 30930898 Free PMC article. Review.
In the last years much attention has focused on the Th17 and Th1 phenotypes and on their pathogenic role in juvenile idiopathic arthritis, investigating how the cytokines produced by T helper cells act on resident cells on the synovia and which signal transduction p …
In the last years much attention has focused on the Th17 and Th1 phenotypes and on their pathogenic role in juvenile idiopathic ar …
177 results